Source: Gait & Posture. Unidade: FM
Subjects: FÁRMACOS (SISTEMA NERVOSO CENTRAL), MARCHA, DOENÇA DE PARKINSON (COMPLICAÇÕES), ESTIMULAÇÃO CEREBRAL
ABNT
SPECIALI, Danielli Souza et al. Validation of GDI, GPS and GVS for use in Parkinson's disease through evaluation of effects of subthalamic deep brain stimulation and levodopa. Gait & Posture, v. 39, n. 4, p. 1142-1145, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.gaitpost.2014.01.011. Acesso em: 07 out. 2024.APA
Speciali, D. S., Corrêa, J. C. F., Luna, N. M., Brant, R., Greve, J. M. D. 'A., Godoy, W. de, et al. (2014). Validation of GDI, GPS and GVS for use in Parkinson's disease through evaluation of effects of subthalamic deep brain stimulation and levodopa. Gait & Posture, 39( 4), 1142-1145. doi:10.1016/j.gaitpost.2014.01.011NLM
Speciali DS, Corrêa JCF, Luna NM, Brant R, Greve JMD'A, Godoy W de, Baker R, Lucareli PRG. Validation of GDI, GPS and GVS for use in Parkinson's disease through evaluation of effects of subthalamic deep brain stimulation and levodopa [Internet]. Gait & Posture. 2014 ; 39( 4): 1142-1145.[citado 2024 out. 07 ] Available from: https://doi.org/10.1016/j.gaitpost.2014.01.011Vancouver
Speciali DS, Corrêa JCF, Luna NM, Brant R, Greve JMD'A, Godoy W de, Baker R, Lucareli PRG. Validation of GDI, GPS and GVS for use in Parkinson's disease through evaluation of effects of subthalamic deep brain stimulation and levodopa [Internet]. Gait & Posture. 2014 ; 39( 4): 1142-1145.[citado 2024 out. 07 ] Available from: https://doi.org/10.1016/j.gaitpost.2014.01.011